Skip to main content
https://pbs.twimg.com/media/FhYksS0XEAI2kWG.jpg
#ACR22 Abs 0256 identified different autoantibodies in ACPA+ and ACPA– RA. Study shows potential utility of serum autoantibodies as diagnostic targets for RA subgroups & treatments. This study reminds me of @RheumNow teaching that not all RA created equal. https://t.co/Fjjk6uC0pB https://t.co/Ozr32cJojr
Dr. Rachel Tate
12-11-2022
×